デフォルト表紙
市場調査レポート
商品コード
1414951

タンパク質アッセイ市場:製品タイプ別、技術別、用途別、エンドユーザー別:世界の機会分析と産業予測 2023-2032年

Protein Assays Market By Product Type, By Technology, By Application, By End User : Global Opportunity Analysis and Industry Forecast, 2023-2032

出版日: | 発行: Allied Market Research | ページ情報: 英文 325 Pages | 納期: 2~3営業日

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=158.97円
タンパク質アッセイ市場:製品タイプ別、技術別、用途別、エンドユーザー別:世界の機会分析と産業予測 2023-2032年
出版日: 2023年11月30日
発行: Allied Market Research
ページ情報: 英文 325 Pages
納期: 2~3営業日
  • 全表示
  • 概要
  • 図表
  • 目次
概要

タンパク質アッセイ市場は、2022年に24億米ドルと評価され、2023年から2032年にかけてCAGR 6.5%で成長し、2032年には45億米ドルに達すると推定されています。

タンパク質アッセイは、ライフサイエンス研究で最も使用される技術の一つです。タンパク質の精製、電気泳動、細胞生物学、分子生物学、その他の科学的応用には、タンパク質濃度の推定が必要です。タンパク質アッセイには多種多様なものがあるが、創薬や疾病診断への応用に適するかどうかをまず検討しなければ、どのアッセイも使用することはできないです。各アッセイにはそれぞれ利点と限界があり、研究用途のために複数の種類のタンパク質アッセイを入手する必要がしばしばあります。

Protein Assays Market-IMG1

タンパク質アッセイの目的は、サンプル中の特定のタンパク質、あるいは異なるタンパク質のアレイの量や濃度を測定することです。タンパク質の分離と検出は、多くの臨床および調査方法で使用されています。これは、研究開発プロセスにおける更なる操作の前の1次調査であったり、構造解析の前のタンパク質の初期捕捉であったり、臨床検査室における疾患診断の一部としての最終検出ステップであったりします。

タンパク質濃度の測定は、対応する中間段階の必要性に関する情報を提供します。タンパク質の定量は、サンプルの全タンパク質含量、またはアフィニティーカラム画分、染料結合タンパク質アッセイ(Bradford)、銅イオンに基づくタンパク質アッセイ(Lowry)、あるいは新しいテストストリップやスポットアプリケーションアッセイなどのような精製されたサブセットに対して必要となります。

世界のタンパク質アッセイ市場の成長を促進する主な要因には、慢性疾患の有病率の上昇、個別化医療に対する需要の急増、創薬開発におけるタンパク質アッセイ法の重要な役割などがあります。さらに、技術的に高度なタンパク質測定キットや試薬、機器の開発のための製薬・バイオテクノロジー業界における研究開発投資の増加、プロテオミクス分野における研究活動の増加は、タンパク質測定試験キットや機器の需要を増加させ、市場の成長を促進する主な要因です。また、主要な市場プレイヤーの増加と、彼らが技術的に高度なタンパク質アッセイ製品の市場開拓のために採用する戦略は、タンパク質アッセイ市場の成長を後押しする主な要因です。例えば、2023年5月、単一細胞および空間生物学のリーダーである10x Genomics, Inc.は、Visium CytAssist空間解析機能の幅を広げるために、新しいVisium CytAssist遺伝子およびタンパク質発現製品の商業的利用を発表しました。Visium CytAssist遺伝子およびタンパク質発現により、研究者は、同一のホルマリン固定パラフィン包埋(FFPE)組織切片から、高度に多重化されたタンパク質および全トランスクリプトームRNAデータを、高い空間分解能で同時にマッピングすることができます。

しかし、タンパク質アッセイに関連する熟練作業者の不足と法外なコストが、タンパク質アッセイ市場の成長を抑制しています。一方、個別化医療に対する需要の急増と医薬品タンパク質の利用拡大は、予測期間中にタンパク質アッセイ市場の成長に有利な機会を提供すると期待されています。

目次

第1章 イントロダクション

第2章 エグゼクティブサマリー

第3章 市場概要

  • 市場の定義と範囲
  • 主な調査結果
    • 影響要因
    • 主な投資機会
  • ポーターのファイブフォース分析
  • 市場力学
    • 促進要因
      • 研究開発活動のための資金増加
      • 慢性疾患の増加
    • 抑制要因
      • タンパク質アッセイに関連する高コスト
    • 機会
      • 医薬品タンパク質の使用拡大

第4章 タンパク質アッセイ市場:製品タイプ別

  • 概要
  • キットおよび試薬
  • 装置と付属品

第5章 タンパク質アッセイ市場:技術別

  • 概要
  • 吸光度ベース
  • 比色ベース
  • 蛍光ベース

第6章 タンパク質アッセイ市場:用途別

  • 概要
  • 創薬と医薬品開発
  • 疾患診断

第7章 タンパク質アッセイ市場:エンドユーザー別

  • 概要
  • 製薬・バイオテクノロジー企業
  • 臨床研究所
  • その他

第8章 タンパク質アッセイ市場:地域別

  • 概要
  • 北米
    • 米国
    • カナダ
    • メキシコ
  • 欧州
    • ドイツ
    • フランス
    • 英国
    • イタリア
    • スペイン
    • その他
  • アジア太平洋
    • 日本
    • 中国
    • オーストラリア
    • インド
    • 韓国
    • その他
  • ラテンアメリカ・中東・アフリカ
    • ブラジル
    • サウジアラビア
    • 南アフリカ
    • その他

第9章 競争情勢

  • イントロダクション
  • 主要成功戦略
  • 主要10社の製品マッピング
  • 競合ダッシュボード
  • 競合ヒートマップ
  • 主要企業のポジショニング(2022年)

第10章 企業プロファイル

  • Sartorius AG
  • Agilent Technologies, Inc.
  • Thermo Fisher Scientific Inc.
  • Perkin Elmer Inc
  • Meril Life Sciences Pvt. Ltd.
  • Cell Signaling Technology
  • Abcam Plc
  • Merck KGaA
  • Bio-Rad Laboratories, Inc.
  • Bio-Techne
図表

LIST OF TABLES

  • TABLE 01. GLOBAL PROTEIN ASSAYS MARKET, BY PRODUCT TYPE, 2022-2032 ($MILLION)
  • TABLE 02. PROTEIN ASSAYS MARKET FOR KITS AND REAGENTS, BY REGION, 2022-2032 ($MILLION)
  • TABLE 03. PROTEIN ASSAYS MARKET FOR INSTRUMENTS AND ACCESSORIES, BY REGION, 2022-2032 ($MILLION)
  • TABLE 04. GLOBAL PROTEIN ASSAYS MARKET, BY TECHNOLOGY, 2022-2032 ($MILLION)
  • TABLE 05. PROTEIN ASSAYS MARKET FOR ABSORBANCE BASED PROTEIN ASSAYS, BY REGION, 2022-2032 ($MILLION)
  • TABLE 06. PROTEIN ASSAYS MARKET FOR COLORIMETRIC BASED PROTEIN ASSAY, BY REGION, 2022-2032 ($MILLION)
  • TABLE 07. PROTEIN ASSAYS MARKET FOR FLUORESCENCE-BASED PROTEIN ASSAYS, BY REGION, 2022-2032 ($MILLION)
  • TABLE 08. GLOBAL PROTEIN ASSAYS MARKET, BY APPLICATION, 2022-2032 ($MILLION)
  • TABLE 09. PROTEIN ASSAYS MARKET FOR DRUG DISCOVERY AND DEVELOPMENT, BY REGION, 2022-2032 ($MILLION)
  • TABLE 10. PROTEIN ASSAYS MARKET FOR DISEASE DIAGNOSIS, BY REGION, 2022-2032 ($MILLION)
  • TABLE 11. GLOBAL PROTEIN ASSAYS MARKET, BY END USER, 2022-2032 ($MILLION)
  • TABLE 12. PROTEIN ASSAYS MARKET FOR PHARMACEUTICAL AND BIOTECHNOLOGY COMPANIES, BY REGION, 2022-2032 ($MILLION)
  • TABLE 13. PROTEIN ASSAYS MARKET FOR CLINICAL LABORATORIES, BY REGION, 2022-2032 ($MILLION)
  • TABLE 14. PROTEIN ASSAYS MARKET FOR OTHERS, BY REGION, 2022-2032 ($MILLION)
  • TABLE 15. PROTEIN ASSAYS MARKET, BY REGION, 2022-2032 ($MILLION)
  • TABLE 16. NORTH AMERICA PROTEIN ASSAYS MARKET, BY PRODUCT TYPE, 2022-2032 ($MILLION)
  • TABLE 17. NORTH AMERICA PROTEIN ASSAYS MARKET, BY TECHNOLOGY, 2022-2032 ($MILLION)
  • TABLE 18. NORTH AMERICA PROTEIN ASSAYS MARKET, BY APPLICATION, 2022-2032 ($MILLION)
  • TABLE 19. NORTH AMERICA PROTEIN ASSAYS MARKET, BY END USER, 2022-2032 ($MILLION)
  • TABLE 20. NORTH AMERICA PROTEIN ASSAYS MARKET, BY COUNTRY, 2022-2032 ($MILLION)
  • TABLE 21. U.S. PROTEIN ASSAYS MARKET, BY PRODUCT TYPE, 2022-2032 ($MILLION)
  • TABLE 22. U.S. PROTEIN ASSAYS MARKET, BY TECHNOLOGY, 2022-2032 ($MILLION)
  • TABLE 23. U.S. PROTEIN ASSAYS MARKET, BY APPLICATION, 2022-2032 ($MILLION)
  • TABLE 24. U.S. PROTEIN ASSAYS MARKET, BY END USER, 2022-2032 ($MILLION)
  • TABLE 25. CANADA PROTEIN ASSAYS MARKET, BY PRODUCT TYPE, 2022-2032 ($MILLION)
  • TABLE 26. CANADA PROTEIN ASSAYS MARKET, BY TECHNOLOGY, 2022-2032 ($MILLION)
  • TABLE 27. CANADA PROTEIN ASSAYS MARKET, BY APPLICATION, 2022-2032 ($MILLION)
  • TABLE 28. CANADA PROTEIN ASSAYS MARKET, BY END USER, 2022-2032 ($MILLION)
  • TABLE 29. MEXICO PROTEIN ASSAYS MARKET, BY PRODUCT TYPE, 2022-2032 ($MILLION)
  • TABLE 30. MEXICO PROTEIN ASSAYS MARKET, BY TECHNOLOGY, 2022-2032 ($MILLION)
  • TABLE 31. MEXICO PROTEIN ASSAYS MARKET, BY APPLICATION, 2022-2032 ($MILLION)
  • TABLE 32. MEXICO PROTEIN ASSAYS MARKET, BY END USER, 2022-2032 ($MILLION)
  • TABLE 33. EUROPE PROTEIN ASSAYS MARKET, BY PRODUCT TYPE, 2022-2032 ($MILLION)
  • TABLE 34. EUROPE PROTEIN ASSAYS MARKET, BY TECHNOLOGY, 2022-2032 ($MILLION)
  • TABLE 35. EUROPE PROTEIN ASSAYS MARKET, BY APPLICATION, 2022-2032 ($MILLION)
  • TABLE 36. EUROPE PROTEIN ASSAYS MARKET, BY END USER, 2022-2032 ($MILLION)
  • TABLE 37. EUROPE PROTEIN ASSAYS MARKET, BY COUNTRY, 2022-2032 ($MILLION)
  • TABLE 38. GERMANY PROTEIN ASSAYS MARKET, BY PRODUCT TYPE, 2022-2032 ($MILLION)
  • TABLE 39. GERMANY PROTEIN ASSAYS MARKET, BY TECHNOLOGY, 2022-2032 ($MILLION)
  • TABLE 40. GERMANY PROTEIN ASSAYS MARKET, BY APPLICATION, 2022-2032 ($MILLION)
  • TABLE 41. GERMANY PROTEIN ASSAYS MARKET, BY END USER, 2022-2032 ($MILLION)
  • TABLE 42. FRANCE PROTEIN ASSAYS MARKET, BY PRODUCT TYPE, 2022-2032 ($MILLION)
  • TABLE 43. FRANCE PROTEIN ASSAYS MARKET, BY TECHNOLOGY, 2022-2032 ($MILLION)
  • TABLE 44. FRANCE PROTEIN ASSAYS MARKET, BY APPLICATION, 2022-2032 ($MILLION)
  • TABLE 45. FRANCE PROTEIN ASSAYS MARKET, BY END USER, 2022-2032 ($MILLION)
  • TABLE 46. UK PROTEIN ASSAYS MARKET, BY PRODUCT TYPE, 2022-2032 ($MILLION)
  • TABLE 47. UK PROTEIN ASSAYS MARKET, BY TECHNOLOGY, 2022-2032 ($MILLION)
  • TABLE 48. UK PROTEIN ASSAYS MARKET, BY APPLICATION, 2022-2032 ($MILLION)
  • TABLE 49. UK PROTEIN ASSAYS MARKET, BY END USER, 2022-2032 ($MILLION)
  • TABLE 50. ITALY PROTEIN ASSAYS MARKET, BY PRODUCT TYPE, 2022-2032 ($MILLION)
  • TABLE 51. ITALY PROTEIN ASSAYS MARKET, BY TECHNOLOGY, 2022-2032 ($MILLION)
  • TABLE 52. ITALY PROTEIN ASSAYS MARKET, BY APPLICATION, 2022-2032 ($MILLION)
  • TABLE 53. ITALY PROTEIN ASSAYS MARKET, BY END USER, 2022-2032 ($MILLION)
  • TABLE 54. SPAIN PROTEIN ASSAYS MARKET, BY PRODUCT TYPE, 2022-2032 ($MILLION)
  • TABLE 55. SPAIN PROTEIN ASSAYS MARKET, BY TECHNOLOGY, 2022-2032 ($MILLION)
  • TABLE 56. SPAIN PROTEIN ASSAYS MARKET, BY APPLICATION, 2022-2032 ($MILLION)
  • TABLE 57. SPAIN PROTEIN ASSAYS MARKET, BY END USER, 2022-2032 ($MILLION)
  • TABLE 58. REST OF EUROPE PROTEIN ASSAYS MARKET, BY PRODUCT TYPE, 2022-2032 ($MILLION)
  • TABLE 59. REST OF EUROPE PROTEIN ASSAYS MARKET, BY TECHNOLOGY, 2022-2032 ($MILLION)
  • TABLE 60. REST OF EUROPE PROTEIN ASSAYS MARKET, BY APPLICATION, 2022-2032 ($MILLION)
  • TABLE 61. REST OF EUROPE PROTEIN ASSAYS MARKET, BY END USER, 2022-2032 ($MILLION)
  • TABLE 62. ASIA-PACIFIC PROTEIN ASSAYS MARKET, BY PRODUCT TYPE, 2022-2032 ($MILLION)
  • TABLE 63. ASIA-PACIFIC PROTEIN ASSAYS MARKET, BY TECHNOLOGY, 2022-2032 ($MILLION)
  • TABLE 64. ASIA-PACIFIC PROTEIN ASSAYS MARKET, BY APPLICATION, 2022-2032 ($MILLION)
  • TABLE 65. ASIA-PACIFIC PROTEIN ASSAYS MARKET, BY END USER, 2022-2032 ($MILLION)
  • TABLE 66. ASIA-PACIFIC PROTEIN ASSAYS MARKET, BY COUNTRY, 2022-2032 ($MILLION)
  • TABLE 67. JAPAN PROTEIN ASSAYS MARKET, BY PRODUCT TYPE, 2022-2032 ($MILLION)
  • TABLE 68. JAPAN PROTEIN ASSAYS MARKET, BY TECHNOLOGY, 2022-2032 ($MILLION)
  • TABLE 69. JAPAN PROTEIN ASSAYS MARKET, BY APPLICATION, 2022-2032 ($MILLION)
  • TABLE 70. JAPAN PROTEIN ASSAYS MARKET, BY END USER, 2022-2032 ($MILLION)
  • TABLE 71. CHINA PROTEIN ASSAYS MARKET, BY PRODUCT TYPE, 2022-2032 ($MILLION)
  • TABLE 72. CHINA PROTEIN ASSAYS MARKET, BY TECHNOLOGY, 2022-2032 ($MILLION)
  • TABLE 73. CHINA PROTEIN ASSAYS MARKET, BY APPLICATION, 2022-2032 ($MILLION)
  • TABLE 74. CHINA PROTEIN ASSAYS MARKET, BY END USER, 2022-2032 ($MILLION)
  • TABLE 75. AUSTRALIA PROTEIN ASSAYS MARKET, BY PRODUCT TYPE, 2022-2032 ($MILLION)
  • TABLE 76. AUSTRALIA PROTEIN ASSAYS MARKET, BY TECHNOLOGY, 2022-2032 ($MILLION)
  • TABLE 77. AUSTRALIA PROTEIN ASSAYS MARKET, BY APPLICATION, 2022-2032 ($MILLION)
  • TABLE 78. AUSTRALIA PROTEIN ASSAYS MARKET, BY END USER, 2022-2032 ($MILLION)
  • TABLE 79. INDIA PROTEIN ASSAYS MARKET, BY PRODUCT TYPE, 2022-2032 ($MILLION)
  • TABLE 80. INDIA PROTEIN ASSAYS MARKET, BY TECHNOLOGY, 2022-2032 ($MILLION)
  • TABLE 81. INDIA PROTEIN ASSAYS MARKET, BY APPLICATION, 2022-2032 ($MILLION)
  • TABLE 82. INDIA PROTEIN ASSAYS MARKET, BY END USER, 2022-2032 ($MILLION)
  • TABLE 83. SOUTH KOREA PROTEIN ASSAYS MARKET, BY PRODUCT TYPE, 2022-2032 ($MILLION)
  • TABLE 84. SOUTH KOREA PROTEIN ASSAYS MARKET, BY TECHNOLOGY, 2022-2032 ($MILLION)
  • TABLE 85. SOUTH KOREA PROTEIN ASSAYS MARKET, BY APPLICATION, 2022-2032 ($MILLION)
  • TABLE 86. SOUTH KOREA PROTEIN ASSAYS MARKET, BY END USER, 2022-2032 ($MILLION)
  • TABLE 87. REST OF ASIA-PACIFIC PROTEIN ASSAYS MARKET, BY PRODUCT TYPE, 2022-2032 ($MILLION)
  • TABLE 88. REST OF ASIA-PACIFIC PROTEIN ASSAYS MARKET, BY TECHNOLOGY, 2022-2032 ($MILLION)
  • TABLE 89. REST OF ASIA-PACIFIC PROTEIN ASSAYS MARKET, BY APPLICATION, 2022-2032 ($MILLION)
  • TABLE 90. REST OF ASIA-PACIFIC PROTEIN ASSAYS MARKET, BY END USER, 2022-2032 ($MILLION)
  • TABLE 91. LAMEA PROTEIN ASSAYS MARKET, BY PRODUCT TYPE, 2022-2032 ($MILLION)
  • TABLE 92. LAMEA PROTEIN ASSAYS MARKET, BY TECHNOLOGY, 2022-2032 ($MILLION)
  • TABLE 93. LAMEA PROTEIN ASSAYS MARKET, BY APPLICATION, 2022-2032 ($MILLION)
  • TABLE 94. LAMEA PROTEIN ASSAYS MARKET, BY END USER, 2022-2032 ($MILLION)
  • TABLE 95. LAMEA PROTEIN ASSAYS MARKET, BY COUNTRY, 2022-2032 ($MILLION)
  • TABLE 96. BRAZIL PROTEIN ASSAYS MARKET, BY PRODUCT TYPE, 2022-2032 ($MILLION)
  • TABLE 97. BRAZIL PROTEIN ASSAYS MARKET, BY TECHNOLOGY, 2022-2032 ($MILLION)
  • TABLE 98. BRAZIL PROTEIN ASSAYS MARKET, BY APPLICATION, 2022-2032 ($MILLION)
  • TABLE 99. BRAZIL PROTEIN ASSAYS MARKET, BY END USER, 2022-2032 ($MILLION)
  • TABLE 100. SAUDI ARABIA PROTEIN ASSAYS MARKET, BY PRODUCT TYPE, 2022-2032 ($MILLION)
  • TABLE 101. SAUDI ARABIA PROTEIN ASSAYS MARKET, BY TECHNOLOGY, 2022-2032 ($MILLION)
  • TABLE 102. SAUDI ARABIA PROTEIN ASSAYS MARKET, BY APPLICATION, 2022-2032 ($MILLION)
  • TABLE 103. SAUDI ARABIA PROTEIN ASSAYS MARKET, BY END USER, 2022-2032 ($MILLION)
  • TABLE 104. SOUTH AFRICA PROTEIN ASSAYS MARKET, BY PRODUCT TYPE, 2022-2032 ($MILLION)
  • TABLE 105. SOUTH AFRICA PROTEIN ASSAYS MARKET, BY TECHNOLOGY, 2022-2032 ($MILLION)
  • TABLE 106. SOUTH AFRICA PROTEIN ASSAYS MARKET, BY APPLICATION, 2022-2032 ($MILLION)
  • TABLE 107. SOUTH AFRICA PROTEIN ASSAYS MARKET, BY END USER, 2022-2032 ($MILLION)
  • TABLE 108. REST OF LAMEA PROTEIN ASSAYS MARKET, BY PRODUCT TYPE, 2022-2032 ($MILLION)
  • TABLE 109. REST OF LAMEA PROTEIN ASSAYS MARKET, BY TECHNOLOGY, 2022-2032 ($MILLION)
  • TABLE 110. REST OF LAMEA PROTEIN ASSAYS MARKET, BY APPLICATION, 2022-2032 ($MILLION)
  • TABLE 111. REST OF LAMEA PROTEIN ASSAYS MARKET, BY END USER, 2022-2032 ($MILLION)
  • TABLE 112. SARTORIUS AG: KEY EXECUTIVES
  • TABLE 113. SARTORIUS AG: COMPANY SNAPSHOT
  • TABLE 114. SARTORIUS AG: PRODUCT SEGMENTS
  • TABLE 115. SARTORIUS AG: PRODUCT PORTFOLIO
  • TABLE 116. SARTORIUS AG: KEY STRATERGIES
  • TABLE 117. AGILENT TECHNOLOGIES, INC.: KEY EXECUTIVES
  • TABLE 118. AGILENT TECHNOLOGIES, INC.: COMPANY SNAPSHOT
  • TABLE 119. AGILENT TECHNOLOGIES, INC.: PRODUCT SEGMENTS
  • TABLE 120. AGILENT TECHNOLOGIES, INC.: PRODUCT PORTFOLIO
  • TABLE 121. THERMO FISHER SCIENTIFIC INC. : KEY EXECUTIVES
  • TABLE 122. THERMO FISHER SCIENTIFIC INC. : COMPANY SNAPSHOT
  • TABLE 123. THERMO FISHER SCIENTIFIC INC. : PRODUCT SEGMENTS
  • TABLE 124. THERMO FISHER SCIENTIFIC INC. : SERVICE SEGMENTS
  • TABLE 125. THERMO FISHER SCIENTIFIC INC. : PRODUCT PORTFOLIO
  • TABLE 126. PERKIN ELMER INC: KEY EXECUTIVES
  • TABLE 127. PERKIN ELMER INC: COMPANY SNAPSHOT
  • TABLE 128. PERKIN ELMER INC: PRODUCT SEGMENTS
  • TABLE 129. PERKIN ELMER INC: PRODUCT PORTFOLIO
  • TABLE 130. MERIL LIFE SCIENCES PVT. LTD.: KEY EXECUTIVES
  • TABLE 131. MERIL LIFE SCIENCES PVT. LTD.: COMPANY SNAPSHOT
  • TABLE 132. MERIL LIFE SCIENCES PVT. LTD.: PRODUCT SEGMENTS
  • TABLE 133. MERIL LIFE SCIENCES PVT. LTD.: PRODUCT PORTFOLIO
  • TABLE 134. CELL SIGNALING TECHNOLOGY: KEY EXECUTIVES
  • TABLE 135. CELL SIGNALING TECHNOLOGY: COMPANY SNAPSHOT
  • TABLE 136. CELL SIGNALING TECHNOLOGY: PRODUCT SEGMENTS
  • TABLE 137. CELL SIGNALING TECHNOLOGY: SERVICE SEGMENTS
  • TABLE 138. CELL SIGNALING TECHNOLOGY: PRODUCT PORTFOLIO
  • TABLE 139. ABCAM PLC: KEY EXECUTIVES
  • TABLE 140. ABCAM PLC: COMPANY SNAPSHOT
  • TABLE 141. ABCAM PLC: SERVICE SEGMENTS
  • TABLE 142. ABCAM PLC: PRODUCT PORTFOLIO
  • TABLE 143. ABCAM PLC: KEY STRATERGIES
  • TABLE 144. MERCK KGAA: KEY EXECUTIVES
  • TABLE 145. MERCK KGAA: COMPANY SNAPSHOT
  • TABLE 146. MERCK KGAA: PRODUCT SEGMENTS
  • TABLE 147. MERCK KGAA: PRODUCT PORTFOLIO
  • TABLE 148. BIO-RAD LABORATORIES, INC. : KEY EXECUTIVES
  • TABLE 149. BIO-RAD LABORATORIES, INC. : COMPANY SNAPSHOT
  • TABLE 150. BIO-RAD LABORATORIES, INC. : PRODUCT SEGMENTS
  • TABLE 151. BIO-RAD LABORATORIES, INC. : PRODUCT PORTFOLIO
  • TABLE 152. BIO-TECHNE: KEY EXECUTIVES
  • TABLE 153. BIO-TECHNE: COMPANY SNAPSHOT
  • TABLE 154. BIO-TECHNE: SERVICE SEGMENTS
  • TABLE 155. BIO-TECHNE: PRODUCT PORTFOLIO

LIST OF FIGURES

  • FIGURE 01. PROTEIN ASSAYS MARKET, 2022-2032
  • FIGURE 02. SEGMENTATION OF PROTEIN ASSAYS MARKET,2022-2032
  • FIGURE 03. TOP IMPACTING FACTORS IN PROTEIN ASSAYS MARKET (2022 TO 2032)
  • FIGURE 04. TOP INVESTMENT POCKETS IN PROTEIN ASSAYS MARKET (2023-2032)
  • FIGURE 05. LOW BARGAINING POWER OF SUPPLIERS
  • FIGURE 06. LOW THREAT OF NEW ENTRANTS
  • FIGURE 07. LOW THREAT OF SUBSTITUTES
  • FIGURE 08. LOW INTENSITY OF RIVALRY
  • FIGURE 09. LOW BARGAINING POWER OF BUYERS
  • FIGURE 10. GLOBAL PROTEIN ASSAYS MARKET:DRIVERS, RESTRAINTS AND OPPORTUNITIES
  • FIGURE 11. PROTEIN ASSAYS MARKET, BY PRODUCT TYPE, 2022 AND 2032(%)
  • FIGURE 12. COMPARATIVE SHARE ANALYSIS OF PROTEIN ASSAYS MARKET FOR KITS AND REAGENTS, BY COUNTRY 2022 AND 2032(%)
  • FIGURE 13. COMPARATIVE SHARE ANALYSIS OF PROTEIN ASSAYS MARKET FOR INSTRUMENTS AND ACCESSORIES, BY COUNTRY 2022 AND 2032(%)
  • FIGURE 14. PROTEIN ASSAYS MARKET, BY TECHNOLOGY, 2022 AND 2032(%)
  • FIGURE 15. COMPARATIVE SHARE ANALYSIS OF PROTEIN ASSAYS MARKET FOR ABSORBANCE BASED PROTEIN ASSAYS, BY COUNTRY 2022 AND 2032(%)
  • FIGURE 16. COMPARATIVE SHARE ANALYSIS OF PROTEIN ASSAYS MARKET FOR COLORIMETRIC BASED PROTEIN ASSAY, BY COUNTRY 2022 AND 2032(%)
  • FIGURE 17. COMPARATIVE SHARE ANALYSIS OF PROTEIN ASSAYS MARKET FOR FLUORESCENCE-BASED PROTEIN ASSAYS, BY COUNTRY 2022 AND 2032(%)
  • FIGURE 18. PROTEIN ASSAYS MARKET, BY APPLICATION, 2022 AND 2032(%)
  • FIGURE 19. COMPARATIVE SHARE ANALYSIS OF PROTEIN ASSAYS MARKET FOR DRUG DISCOVERY AND DEVELOPMENT, BY COUNTRY 2022 AND 2032(%)
  • FIGURE 20. COMPARATIVE SHARE ANALYSIS OF PROTEIN ASSAYS MARKET FOR DISEASE DIAGNOSIS, BY COUNTRY 2022 AND 2032(%)
  • FIGURE 21. PROTEIN ASSAYS MARKET, BY END USER, 2022 AND 2032(%)
  • FIGURE 22. COMPARATIVE SHARE ANALYSIS OF PROTEIN ASSAYS MARKET FOR PHARMACEUTICAL AND BIOTECHNOLOGY COMPANIES, BY COUNTRY 2022 AND 2032(%)
  • FIGURE 23. COMPARATIVE SHARE ANALYSIS OF PROTEIN ASSAYS MARKET FOR CLINICAL LABORATORIES, BY COUNTRY 2022 AND 2032(%)
  • FIGURE 24. COMPARATIVE SHARE ANALYSIS OF PROTEIN ASSAYS MARKET FOR OTHERS, BY COUNTRY 2022 AND 2032(%)
  • FIGURE 25. PROTEIN ASSAYS MARKET BY REGION, 2022 AND 2032(%)
  • FIGURE 26. U.S. PROTEIN ASSAYS MARKET, 2022-2032 ($MILLION)
  • FIGURE 27. CANADA PROTEIN ASSAYS MARKET, 2022-2032 ($MILLION)
  • FIGURE 28. MEXICO PROTEIN ASSAYS MARKET, 2022-2032 ($MILLION)
  • FIGURE 29. GERMANY PROTEIN ASSAYS MARKET, 2022-2032 ($MILLION)
  • FIGURE 30. FRANCE PROTEIN ASSAYS MARKET, 2022-2032 ($MILLION)
  • FIGURE 31. UK PROTEIN ASSAYS MARKET, 2022-2032 ($MILLION)
  • FIGURE 32. ITALY PROTEIN ASSAYS MARKET, 2022-2032 ($MILLION)
  • FIGURE 33. SPAIN PROTEIN ASSAYS MARKET, 2022-2032 ($MILLION)
  • FIGURE 34. REST OF EUROPE PROTEIN ASSAYS MARKET, 2022-2032 ($MILLION)
  • FIGURE 35. JAPAN PROTEIN ASSAYS MARKET, 2022-2032 ($MILLION)
  • FIGURE 36. CHINA PROTEIN ASSAYS MARKET, 2022-2032 ($MILLION)
  • FIGURE 37. AUSTRALIA PROTEIN ASSAYS MARKET, 2022-2032 ($MILLION)
  • FIGURE 38. INDIA PROTEIN ASSAYS MARKET, 2022-2032 ($MILLION)
  • FIGURE 39. SOUTH KOREA PROTEIN ASSAYS MARKET, 2022-2032 ($MILLION)
  • FIGURE 40. REST OF ASIA-PACIFIC PROTEIN ASSAYS MARKET, 2022-2032 ($MILLION)
  • FIGURE 41. BRAZIL PROTEIN ASSAYS MARKET, 2022-2032 ($MILLION)
  • FIGURE 42. SAUDI ARABIA PROTEIN ASSAYS MARKET, 2022-2032 ($MILLION)
  • FIGURE 43. SOUTH AFRICA PROTEIN ASSAYS MARKET, 2022-2032 ($MILLION)
  • FIGURE 44. REST OF LAMEA PROTEIN ASSAYS MARKET, 2022-2032 ($MILLION)
  • FIGURE 45. TOP WINNING STRATEGIES, BY YEAR (2021-2023)
  • FIGURE 46. TOP WINNING STRATEGIES, BY DEVELOPMENT (2021-2023)
  • FIGURE 47. TOP WINNING STRATEGIES, BY COMPANY (2021-2023)
  • FIGURE 48. PRODUCT MAPPING OF TOP 10 PLAYERS
  • FIGURE 49. COMPETITIVE DASHBOARD
  • FIGURE 50. COMPETITIVE HEATMAP: PROTEIN ASSAYS MARKET
  • FIGURE 51. TOP PLAYER POSITIONING, 2022
  • FIGURE 52. SARTORIUS AG: NET SALES, 2020-2022 ($MILLION)
  • FIGURE 53. SARTORIUS AG: REVENUE SHARE BY SEGMENT, 2022 (%)
  • FIGURE 54. SARTORIUS AG: REVENUE SHARE BY REGION, 2022 (%)
  • FIGURE 55. AGILENT TECHNOLOGIES, INC.: NET REVENUE, 2020-2022 ($MILLION)
  • FIGURE 56. AGILENT TECHNOLOGIES, INC.: RESEARCH & DEVELOPMENT EXPENDITURE, 2020-2022 ($MILLION)
  • FIGURE 57. AGILENT TECHNOLOGIES, INC.: REVENUE SHARE BY SEGMENT, 2022 (%)
  • FIGURE 58. AGILENT TECHNOLOGIES, INC.: REVENUE SHARE BY REGION, 2022 (%)
  • FIGURE 59. THERMO FISHER SCIENTIFIC INC. : NET REVENUE, 2020-2022 ($MILLION)
  • FIGURE 60. THERMO FISHER SCIENTIFIC INC. : REVENUE SHARE BY SEGMENT, 2022 (%)
  • FIGURE 61. THERMO FISHER SCIENTIFIC INC. : REVENUE SHARE BY REGION, 2022 (%)
  • FIGURE 62. PERKIN ELMER INC: NET REVENUE, 2020-2022 ($MILLION)
  • FIGURE 63. PERKIN ELMER INC: REVENUE SHARE BY SEGMENT, 2021 (%)
  • FIGURE 64. PERKIN ELMER INC: REVENUE SHARE BY REGION, 2022 (%)
  • FIGURE 65. ABCAM PLC: NET REVENUE, 2020-2022 ($MILLION)
  • FIGURE 66. ABCAM PLC: REVENUE SHARE BY REGION, 2022 (%)
  • FIGURE 67. MERCK KGAA: NET SALES, 2020-2022 ($MILLION)
  • FIGURE 68. MERCK KGAA: REVENUE SHARE BY SEGMENT, 2022 (%)
  • FIGURE 69. MERCK KGAA: REVENUE SHARE BY REGION, 2022 (%)
  • FIGURE 70. BIO-RAD LABORATORIES, INC. : NET SALES, 2020-2022 ($MILLION)
  • FIGURE 71. BIO-RAD LABORATORIES, INC. : REVENUE SHARE BY SEGMENT, 2022 (%)
  • FIGURE 72. BIO-RAD LABORATORIES, INC. : REVENUE SHARE BY REGION, 2022 (%)
  • FIGURE 73. BIO-TECHNE: NET REVENUE, 2020-2022 ($MILLION)
  • FIGURE 74. BIO-TECHNE: REVENUE SHARE BY REGION, 2022 (%)
  • FIGURE 75. BIO-TECHNE: REVENUE SHARE BY SEGMENT, 2022 (%)
目次
Product Code: A06187

According to a new report published by Allied Market Research, titled, "Protein Assays Market," The protein assays market was valued at $2.4 billion in 2022, and is estimated to reach $4.5 billion by 2032, growing at a CAGR of 6.5% from 2023 to 2032. Protein assays is one of the most used techniques in life science research. Protein purification, electrophoresis, cell biology, molecular biology, and other scientific applications require the estimation of protein concentration. Although there are a wide variety of protein assays available, none of the assays can be used without first considering their suitability for the application in drug discovery and disease diagnosis. Each assay has its own advantages and limitations and often it is necessary to obtain more than one type of protein assay for research applications.

Protein Assays Market - IMG1

The purpose of protein assay is to determine the amount or concentration of a specific protein or an array of different proteins in a sample. Isolating and detecting protein is used for many clinical and research processes. This can be a primary step before further manipulation in a research and development process, an initial capture of protein before structural analysis, or it can be a final detection step in a clinical laboratory as part of a disease diagnosis.

The determination of protein concentrations provides information about the necessity of corresponding intermediate steps. Protein quantitation could either be required for the total protein content of a sample, or for purified subsets thereof, such as affinity column fractions. There are various methods for protein assays such as dye binding protein assays (Bradford), protein assays based on copper ions (Lowry), or a novel test strip and spot application assay.

Major factors that drive the growth of the global protein assays market include rise in prevalence of chronic disease, upsurge in demand for personalized medicine, and critical role of protein assay method in drug discovery and development. Furthermore, increase in R&D investment in pharmaceutical & biotechnology industries for the development of technologically advanced protein assay kits and reagents and instruments and increase in the number of research activities in the field of proteomics are the major factors that increase the demand for protein assays tests kits and instruments and hence propel the growth of the market. In addition, increase in number of key market players and strategies they adopt for the development of technologically advanced protein assays products are the major factors that boost the growth of the protein assays market. For instance, in May 2023, 10x Genomics, Inc. a leader in single cell and spatial biology, announced the commercial availability of a new Visium CytAssist gene and protein expression product to expand the breadth of the Visium CytAssist spatial analysis capabilities. Visium CytAssist gene and protein expression enables researchers to simultaneously produce highly multiplexed protein and whole transcriptome RNA data mapped together from the same formalin-fixed, paraffin-embedded (FFPE) tissue section at high spatial resolution.

However, the lack of skilled workers and prohibitive cost associated with protein assay restrain the growth of the protein assays market. On the contrary, surge in demand for personalized medicine and expansion in the use of drug proteins are expected to provide lucrative opportunities for the growth of the protein assays market during the forecast period.

The protein assays market is segmented into product type, technology, application, end user, and region. Based on product type, the market is bifurcated into kits & reagents and instruments and accessories. Based on technology, it is divided into absorbance-based protein assay, colorimetric based protein assay and fluorescence-based protein assays. Based on application, it is classified into drug discovery and development and disease diagnosis. Based on end user, it is divided into pharmaceutical and biotechnology companies, clinical laboratories, and others. On the basis of region, it is analyzed across North America (the U.S., Canada, and Mexico), Europe (Germany, France, the UK, Italy, Spain, and rest of Europe), Asia-Pacific (China, Japan, Australia, India, South Korea, and rest of Asia-Pacific), and LAMEA (Brazil, South Africa, Saudi Arabia, and rest of LAMEA).

The major players profiled in the report are Sartorius AG, Agilent Technologies, Inc., Thermo Fisher Scientific Inc., Perkin Elmer Inc., Meril Life Sciences Pvt. Ltd., Abcam PLC, Cell Signaling Technology, Merck KGaA, Bio-Rad Laboratories Inc, and Bio-Techne. The key players such as Sartorius AG and Abcam PLC have adopted product launch, acquisition, and partnership as major developmental strategies to improve the product portfolio.

Key Benefits For Stakeholders

  • This report provides a quantitative analysis of the market segments, current trends, estimations, and dynamics of the protein assays market analysis from 2022 to 2032 to identify the prevailing protein assays market opportunities.
  • The market research is offered along with information related to key drivers, restraints, and opportunities.
  • Porter's five forces analysis highlights the potency of buyers and suppliers to enable stakeholders make profit-oriented business decisions and strengthen their supplier-buyer network.
  • In-depth analysis of the protein assays market segmentation assists to determine the prevailing market opportunities.
  • Major countries in each region are mapped according to their revenue contribution to the global market.
  • Market player positioning facilitates benchmarking and provides a clear understanding of the present position of the market players.
  • The report includes the analysis of the regional as well as global protein assays market trends, key players, market segments, application areas, and market growth strategies.

Additional benefits you will get with this purchase are:

  • Quarterly Update and* (only available with a corporate license, on listed price)
  • 5 additional Company Profile of client Choice pre- or Post-purchase, as a free update.
  • Free Upcoming Version on the Purchase of Five and Enterprise User License.
  • 16 analyst hours of support* (post-purchase, if you find additional data requirements upon review of the report, you may receive support amounting to 16 analyst hours to solve questions, and post-sale queries)
  • 15% Free Customization* (in case the scope or segment of the report does not match your requirements, 15% is equivalent to 3 working days of free work, applicable once)
  • Free data Pack on the Five and Enterprise User License. (Excel version of the report)
  • Free Updated report if the report is 6-12 months old or older.
  • 24-hour priority response*
  • Free Industry updates and white papers.

Possible Customization with this report (with additional cost and timeline, please talk to the sales executive to know more)

  • Market share analysis of players by products/segments
  • New Product Development/ Product Matrix of Key Players
  • Additional company profiles with specific to client's interest
  • Additional country or region analysis- market size and forecast
  • Average Selling Price Analysis / Price Point Analysis
  • Expanded list for Company Profiles
  • Historic market data
  • SWOT Analysis

Key Market Segments

By Application

  • Drug Discovery and Development
  • Disease Diagnosis

By Product Type

  • Kits and Reagents
  • Instruments and Accessories

By Technology

  • Absorbance Based Protein Assays
  • Colorimetric based protein assay
  • Fluorescence-Based Protein Assays

By End User

  • Pharmaceutical and biotechnology companies
  • Clinical Laboratories
  • Others

By Region

  • North America
    • U.S.
    • Canada
    • Mexico
  • Europe
    • Germany
    • France
    • UK
    • Italy
    • Spain
    • Rest of Europe
  • Asia-Pacific
    • Japan
    • China
    • Australia
    • India
    • South Korea
    • Rest of Asia-Pacific
  • LAMEA
    • Brazil
    • Saudi Arabia
    • South Africa
    • Rest of LAMEA

Key Market Players:

    • Agilent Technologies, Inc.
    • Perkin Elmer Inc
    • Abcam Plc
    • Meril Life Sciences Pvt. Ltd.
    • Cell Signaling Technology
    • Sartorius AG
    • Thermo Fisher Scientific Inc.
    • Merck KGaA
    • Bio-Rad Laboratories, Inc.
    • Bio-Techne

TABLE OF CONTENTS

CHAPTER 1: INTRODUCTION

  • 1.1. Report description
  • 1.2. Key market segments
  • 1.3. Key benefits to the stakeholders
  • 1.4. Research methodology
    • 1.4.1. Primary research
    • 1.4.2. Secondary research
    • 1.4.3. Analyst tools and models

CHAPTER 2: EXECUTIVE SUMMARY

  • 2.1. CXO Perspective

CHAPTER 3: MARKET OVERVIEW

  • 3.1. Market definition and scope
  • 3.2. Key findings
    • 3.2.1. Top impacting factors
    • 3.2.2. Top investment pockets
  • 3.3. Porter's five forces analysis
    • 3.3.1. Low bargaining power of suppliers
    • 3.3.2. Low threat of new entrants
    • 3.3.3. Low threat of substitutes
    • 3.3.4. Low intensity of rivalry
    • 3.3.5. Low bargaining power of buyers
  • 3.4. Market dynamics
    • 3.4.1. Drivers
      • 3.4.1.1. Increase in funding for R&D activities
      • 3.4.1.2. Rise in prevalence of chronic disease
    • 3.4.2. Restraints
      • 3.4.2.1. High cost associated with protein assays
    • 3.4.3. Opportunities
      • 3.4.3.1. Expansion in the use of drug protein

CHAPTER 4: PROTEIN ASSAYS MARKET, BY PRODUCT TYPE

  • 4.1. Overview
    • 4.1.1. Market size and forecast
  • 4.2. Kits and Reagents
    • 4.2.1. Key market trends, growth factors and opportunities
    • 4.2.2. Market size and forecast, by region
    • 4.2.3. Market share analysis by country
  • 4.3. Instruments and Accessories
    • 4.3.1. Key market trends, growth factors and opportunities
    • 4.3.2. Market size and forecast, by region
    • 4.3.3. Market share analysis by country

CHAPTER 5: PROTEIN ASSAYS MARKET, BY TECHNOLOGY

  • 5.1. Overview
    • 5.1.1. Market size and forecast
  • 5.2. Absorbance Based Protein Assays
    • 5.2.1. Key market trends, growth factors and opportunities
    • 5.2.2. Market size and forecast, by region
    • 5.2.3. Market share analysis by country
  • 5.3. Colorimetric based protein assay
    • 5.3.1. Key market trends, growth factors and opportunities
    • 5.3.2. Market size and forecast, by region
    • 5.3.3. Market share analysis by country
  • 5.4. Fluorescence-Based Protein Assays
    • 5.4.1. Key market trends, growth factors and opportunities
    • 5.4.2. Market size and forecast, by region
    • 5.4.3. Market share analysis by country

CHAPTER 6: PROTEIN ASSAYS MARKET, BY APPLICATION

  • 6.1. Overview
    • 6.1.1. Market size and forecast
  • 6.2. Drug Discovery and Development
    • 6.2.1. Key market trends, growth factors and opportunities
    • 6.2.2. Market size and forecast, by region
    • 6.2.3. Market share analysis by country
  • 6.3. Disease Diagnosis
    • 6.3.1. Key market trends, growth factors and opportunities
    • 6.3.2. Market size and forecast, by region
    • 6.3.3. Market share analysis by country

CHAPTER 7: PROTEIN ASSAYS MARKET, BY END USER

  • 7.1. Overview
    • 7.1.1. Market size and forecast
  • 7.2. Pharmaceutical and biotechnology companies
    • 7.2.1. Key market trends, growth factors and opportunities
    • 7.2.2. Market size and forecast, by region
    • 7.2.3. Market share analysis by country
  • 7.3. Clinical Laboratories
    • 7.3.1. Key market trends, growth factors and opportunities
    • 7.3.2. Market size and forecast, by region
    • 7.3.3. Market share analysis by country
  • 7.4. Others
    • 7.4.1. Key market trends, growth factors and opportunities
    • 7.4.2. Market size and forecast, by region
    • 7.4.3. Market share analysis by country

CHAPTER 8: PROTEIN ASSAYS MARKET, BY REGION

  • 8.1. Overview
    • 8.1.1. Market size and forecast By Region
  • 8.2. North America
    • 8.2.1. Key market trends, growth factors and opportunities
    • 8.2.2. Market size and forecast, by Product Type
    • 8.2.3. Market size and forecast, by Technology
    • 8.2.4. Market size and forecast, by Application
    • 8.2.5. Market size and forecast, by End User
    • 8.2.6. Market size and forecast, by country
      • 8.2.6.1. U.S.
      • 8.2.6.1.1. Market size and forecast, by Product Type
      • 8.2.6.1.2. Market size and forecast, by Technology
      • 8.2.6.1.3. Market size and forecast, by Application
      • 8.2.6.1.4. Market size and forecast, by End User
      • 8.2.6.2. Canada
      • 8.2.6.2.1. Market size and forecast, by Product Type
      • 8.2.6.2.2. Market size and forecast, by Technology
      • 8.2.6.2.3. Market size and forecast, by Application
      • 8.2.6.2.4. Market size and forecast, by End User
      • 8.2.6.3. Mexico
      • 8.2.6.3.1. Market size and forecast, by Product Type
      • 8.2.6.3.2. Market size and forecast, by Technology
      • 8.2.6.3.3. Market size and forecast, by Application
      • 8.2.6.3.4. Market size and forecast, by End User
  • 8.3. Europe
    • 8.3.1. Key market trends, growth factors and opportunities
    • 8.3.2. Market size and forecast, by Product Type
    • 8.3.3. Market size and forecast, by Technology
    • 8.3.4. Market size and forecast, by Application
    • 8.3.5. Market size and forecast, by End User
    • 8.3.6. Market size and forecast, by country
      • 8.3.6.1. Germany
      • 8.3.6.1.1. Market size and forecast, by Product Type
      • 8.3.6.1.2. Market size and forecast, by Technology
      • 8.3.6.1.3. Market size and forecast, by Application
      • 8.3.6.1.4. Market size and forecast, by End User
      • 8.3.6.2. France
      • 8.3.6.2.1. Market size and forecast, by Product Type
      • 8.3.6.2.2. Market size and forecast, by Technology
      • 8.3.6.2.3. Market size and forecast, by Application
      • 8.3.6.2.4. Market size and forecast, by End User
      • 8.3.6.3. UK
      • 8.3.6.3.1. Market size and forecast, by Product Type
      • 8.3.6.3.2. Market size and forecast, by Technology
      • 8.3.6.3.3. Market size and forecast, by Application
      • 8.3.6.3.4. Market size and forecast, by End User
      • 8.3.6.4. Italy
      • 8.3.6.4.1. Market size and forecast, by Product Type
      • 8.3.6.4.2. Market size and forecast, by Technology
      • 8.3.6.4.3. Market size and forecast, by Application
      • 8.3.6.4.4. Market size and forecast, by End User
      • 8.3.6.5. Spain
      • 8.3.6.5.1. Market size and forecast, by Product Type
      • 8.3.6.5.2. Market size and forecast, by Technology
      • 8.3.6.5.3. Market size and forecast, by Application
      • 8.3.6.5.4. Market size and forecast, by End User
      • 8.3.6.6. Rest of Europe
      • 8.3.6.6.1. Market size and forecast, by Product Type
      • 8.3.6.6.2. Market size and forecast, by Technology
      • 8.3.6.6.3. Market size and forecast, by Application
      • 8.3.6.6.4. Market size and forecast, by End User
  • 8.4. Asia-Pacific
    • 8.4.1. Key market trends, growth factors and opportunities
    • 8.4.2. Market size and forecast, by Product Type
    • 8.4.3. Market size and forecast, by Technology
    • 8.4.4. Market size and forecast, by Application
    • 8.4.5. Market size and forecast, by End User
    • 8.4.6. Market size and forecast, by country
      • 8.4.6.1. Japan
      • 8.4.6.1.1. Market size and forecast, by Product Type
      • 8.4.6.1.2. Market size and forecast, by Technology
      • 8.4.6.1.3. Market size and forecast, by Application
      • 8.4.6.1.4. Market size and forecast, by End User
      • 8.4.6.2. China
      • 8.4.6.2.1. Market size and forecast, by Product Type
      • 8.4.6.2.2. Market size and forecast, by Technology
      • 8.4.6.2.3. Market size and forecast, by Application
      • 8.4.6.2.4. Market size and forecast, by End User
      • 8.4.6.3. Australia
      • 8.4.6.3.1. Market size and forecast, by Product Type
      • 8.4.6.3.2. Market size and forecast, by Technology
      • 8.4.6.3.3. Market size and forecast, by Application
      • 8.4.6.3.4. Market size and forecast, by End User
      • 8.4.6.4. India
      • 8.4.6.4.1. Market size and forecast, by Product Type
      • 8.4.6.4.2. Market size and forecast, by Technology
      • 8.4.6.4.3. Market size and forecast, by Application
      • 8.4.6.4.4. Market size and forecast, by End User
      • 8.4.6.5. South Korea
      • 8.4.6.5.1. Market size and forecast, by Product Type
      • 8.4.6.5.2. Market size and forecast, by Technology
      • 8.4.6.5.3. Market size and forecast, by Application
      • 8.4.6.5.4. Market size and forecast, by End User
      • 8.4.6.6. Rest of Asia-Pacific
      • 8.4.6.6.1. Market size and forecast, by Product Type
      • 8.4.6.6.2. Market size and forecast, by Technology
      • 8.4.6.6.3. Market size and forecast, by Application
      • 8.4.6.6.4. Market size and forecast, by End User
  • 8.5. LAMEA
    • 8.5.1. Key market trends, growth factors and opportunities
    • 8.5.2. Market size and forecast, by Product Type
    • 8.5.3. Market size and forecast, by Technology
    • 8.5.4. Market size and forecast, by Application
    • 8.5.5. Market size and forecast, by End User
    • 8.5.6. Market size and forecast, by country
      • 8.5.6.1. Brazil
      • 8.5.6.1.1. Market size and forecast, by Product Type
      • 8.5.6.1.2. Market size and forecast, by Technology
      • 8.5.6.1.3. Market size and forecast, by Application
      • 8.5.6.1.4. Market size and forecast, by End User
      • 8.5.6.2. Saudi Arabia
      • 8.5.6.2.1. Market size and forecast, by Product Type
      • 8.5.6.2.2. Market size and forecast, by Technology
      • 8.5.6.2.3. Market size and forecast, by Application
      • 8.5.6.2.4. Market size and forecast, by End User
      • 8.5.6.3. South Africa
      • 8.5.6.3.1. Market size and forecast, by Product Type
      • 8.5.6.3.2. Market size and forecast, by Technology
      • 8.5.6.3.3. Market size and forecast, by Application
      • 8.5.6.3.4. Market size and forecast, by End User
      • 8.5.6.4. Rest of LAMEA
      • 8.5.6.4.1. Market size and forecast, by Product Type
      • 8.5.6.4.2. Market size and forecast, by Technology
      • 8.5.6.4.3. Market size and forecast, by Application
      • 8.5.6.4.4. Market size and forecast, by End User

CHAPTER 9: COMPETITIVE LANDSCAPE

  • 9.1. Introduction
  • 9.2. Top winning strategies
  • 9.3. Product mapping of top 10 player
  • 9.4. Competitive dashboard
  • 9.5. Competitive heatmap
  • 9.6. Top player positioning, 2022

CHAPTER 10: COMPANY PROFILES

  • 10.1. Sartorius AG
    • 10.1.1. Company overview
    • 10.1.2. Key executives
    • 10.1.3. Company snapshot
    • 10.1.4. Operating business segments
    • 10.1.5. Product portfolio
    • 10.1.6. Business performance
    • 10.1.7. Key strategic moves and developments
  • 10.2. Agilent Technologies, Inc.
    • 10.2.1. Company overview
    • 10.2.2. Key executives
    • 10.2.3. Company snapshot
    • 10.2.4. Operating business segments
    • 10.2.5. Product portfolio
    • 10.2.6. Business performance
  • 10.3. Thermo Fisher Scientific Inc.
    • 10.3.1. Company overview
    • 10.3.2. Key executives
    • 10.3.3. Company snapshot
    • 10.3.4. Operating business segments
    • 10.3.5. Product portfolio
    • 10.3.6. Business performance
  • 10.4. Perkin Elmer Inc
    • 10.4.1. Company overview
    • 10.4.2. Key executives
    • 10.4.3. Company snapshot
    • 10.4.4. Operating business segments
    • 10.4.5. Product portfolio
    • 10.4.6. Business performance
  • 10.5. Meril Life Sciences Pvt. Ltd.
    • 10.5.1. Company overview
    • 10.5.2. Key executives
    • 10.5.3. Company snapshot
    • 10.5.4. Operating business segments
    • 10.5.5. Product portfolio
  • 10.6. Cell Signaling Technology
    • 10.6.1. Company overview
    • 10.6.2. Key executives
    • 10.6.3. Company snapshot
    • 10.6.4. Operating business segments
    • 10.6.5. Product portfolio
  • 10.7. Abcam Plc
    • 10.7.1. Company overview
    • 10.7.2. Key executives
    • 10.7.3. Company snapshot
    • 10.7.4. Operating business segments
    • 10.7.5. Product portfolio
    • 10.7.6. Business performance
    • 10.7.7. Key strategic moves and developments
  • 10.8. Merck KGaA
    • 10.8.1. Company overview
    • 10.8.2. Key executives
    • 10.8.3. Company snapshot
    • 10.8.4. Operating business segments
    • 10.8.5. Product portfolio
    • 10.8.6. Business performance
  • 10.9. Bio-Rad Laboratories, Inc.
    • 10.9.1. Company overview
    • 10.9.2. Key executives
    • 10.9.3. Company snapshot
    • 10.9.4. Operating business segments
    • 10.9.5. Product portfolio
    • 10.9.6. Business performance
  • 10.10. Bio-Techne
    • 10.10.1. Company overview
    • 10.10.2. Key executives
    • 10.10.3. Company snapshot
    • 10.10.4. Operating business segments
    • 10.10.5. Product portfolio
    • 10.10.6. Business performance